Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza
Clinical trial NCT06817096 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06817096
- Sponsor
- Azidus Brasil
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-12-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.